BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 29403275)

  • 1. Development of biocompatible and VEGF-targeted paclitaxel nanodrugs on albumin and graphene oxide dual-carrier for photothermal-triggered drug delivery in vitro and in vivo.
    Deng W; Qiu J; Wang S; Yuan Z; Jia Y; Tan H; Lu J; Zheng R
    Int J Nanomedicine; 2018; 13():439-453. PubMed ID: 29403275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folate-receptor-targeted laser-activable poly(lactide-
    Liu F; Chen Y; Li Y; Guo Y; Cao Y; Li P; Wang Z; Gong Y; Ran H
    Int J Nanomedicine; 2018; 13():5139-5158. PubMed ID: 30233177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A light-controllable specific drug delivery nanoplatform for targeted bimodal imaging-guided photothermal/chemo synergistic cancer therapy.
    Guo Y; Wang XY; Chen YL; Liu FQ; Tan MX; Ao M; Yu JH; Ran HT; Wang ZX
    Acta Biomater; 2018 Oct; 80():308-326. PubMed ID: 30240955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Graphene oxide (GO)-based nanosheets with combined chemo/photothermal/photodynamic therapy to overcome gastric cancer (GC) paclitaxel resistance by reducing mitochondria-derived adenosine-triphosphate (ATP).
    Guo W; Chen Z; Feng X; Shen G; Huang H; Liang Y; Zhao B; Li G; Hu Y
    J Nanobiotechnology; 2021 May; 19(1):146. PubMed ID: 34011375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Facile one-pot formulation of TRAIL-embedded paclitaxel-bound albumin nanoparticles for the treatment of pancreatic cancer.
    Min SY; Byeon HJ; Lee C; Seo J; Lee ES; Shin BS; Choi HG; Lee KC; Youn YS
    Int J Pharm; 2015 Oct; 494(1):506-15. PubMed ID: 26315118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paclitaxel/IR1061-Co-Loaded Protein Nanoparticle for Tumor-Targeted and pH/NIR-II-Triggered Synergistic Photothermal-Chemotherapy.
    He L; Qing F; Li M; Lan D
    Int J Nanomedicine; 2020; 15():2337-2349. PubMed ID: 32308385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A personalized and long-acting local therapeutic platform combining photothermal therapy and chemotherapy for the treatment of multidrug-resistant colon tumor.
    Wang B; Wu S; Lin Z; Jiang Y; Chen Y; Chen ZS; Yang X; Gao W
    Int J Nanomedicine; 2018; 13():8411-8427. PubMed ID: 30587968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Graphene quantum dots-gated hollow mesoporous carbon nanoplatform for targeting drug delivery and synergistic chemo-photothermal therapy.
    Fang J; Liu Y; Chen Y; Ouyang D; Yang G; Yu T
    Int J Nanomedicine; 2018; 13():5991-6007. PubMed ID: 30323587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A tumor-targeting near-infrared laser-triggered drug delivery system based on GO@Ag nanoparticles for chemo-photothermal therapy and X-ray imaging.
    Shi J; Wang L; Zhang J; Ma R; Gao J; Liu Y; Zhang C; Zhang Z
    Biomaterials; 2014 Jul; 35(22):5847-61. PubMed ID: 24746963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multifunctional Mesoporous Polydopamine With Hydrophobic Paclitaxel For Photoacoustic Imaging-Guided Chemo-Photothermal Synergistic Therapy.
    Zhang L; Yang P; Guo R; Sun J; Xie R; Yang W
    Int J Nanomedicine; 2019; 14():8647-8663. PubMed ID: 31806962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aerosol technique-based carbon-encapsulated hollow mesoporous silica nanoparticles for synergistic chemo-photothermal therapy.
    Gautam M; Thapa RK; Poudel BK; Gupta B; Ruttala HB; Nguyen HT; Soe ZC; Ou W; Poudel K; Choi HG; Ku SK; Yong CS; Kim JO
    Acta Biomater; 2019 Apr; 88():448-461. PubMed ID: 30818051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Covalent functionalization of graphene oxide with biocompatible poly(ethylene glycol) for delivery of paclitaxel.
    Xu Z; Wang S; Li Y; Wang M; Shi P; Huang X
    ACS Appl Mater Interfaces; 2014 Oct; 6(19):17268-76. PubMed ID: 25216036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MHI-148 Cyanine Dye Conjugated Chitosan Nanomicelle with NIR Light-Trigger Release Property as Cancer Targeting Theranostic Agent.
    Thomas RG; Moon MJ; Surendran SP; Park HJ; Park IK; Lee BI; Jeong YY
    Mol Imaging Biol; 2018 Aug; 20(4):533-543. PubMed ID: 29450802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Co-delivery of cisplatin and paclitaxel by folic acid conjugated amphiphilic PEG-PLGA copolymer nanoparticles for the treatment of non-small lung cancer.
    He Z; Huang J; Xu Y; Zhang X; Teng Y; Huang C; Wu Y; Zhang X; Zhang H; Sun W
    Oncotarget; 2015 Dec; 6(39):42150-68. PubMed ID: 26517524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Self-promoted Albumin-Based Nanoparticles for Combination Therapy against Metastatic Breast Cancer via a Hyperthermia-Induced "Platelet Bridge".
    Zhao W; Li T; Long Y; Guo R; Sheng Q; Lu Z; Li M; Li J; Zang S; Zhang Z; He Q
    ACS Appl Mater Interfaces; 2021 Jun; 13(22):25701-25714. PubMed ID: 34041901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peptide-conjugated biodegradable nanoparticles as a carrier to target paclitaxel to tumor neovasculature.
    Yu DH; Lu Q; Xie J; Fang C; Chen HZ
    Biomaterials; 2010 Mar; 31(8):2278-92. PubMed ID: 20053444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low density lipoprotein mimic nanoparticles composed of amphipathic hybrid peptides and lipids for tumor-targeted delivery of paclitaxel.
    Qian J; Xu N; Zhou X; Shi K; Du Q; Yin X; Zhao Z
    Int J Nanomedicine; 2019; 14():7431-7446. PubMed ID: 31686815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Melanin-loaded biocompatible photosensitive nanoparticles for controlled drug release in combined photothermal-chemotherapy guided by photoacoustic/ultrasound dual-modality imaging.
    Wang W; Jing T; Xia X; Tang L; Huang Z; Liu F; Wang Z; Ran H; Li M; Xia J
    Biomater Sci; 2019 Oct; 7(10):4060-4074. PubMed ID: 31475710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Near-infrared light triggered drug delivery system for higher efficacy of combined chemo-photothermal treatment.
    Chen Y; Li H; Deng Y; Sun H; Ke X; Ci T
    Acta Biomater; 2017 Mar; 51():374-392. PubMed ID: 28088668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduction-Responsive and Multidrug Deliverable Albumin Nanoparticles: An Antitumor Drug to Abraxane against Human Pancreatic Tumor-Bearing Mice.
    Hirakawa N; Ishima Y; Kinoshita R; Nakano R; Chuang VTG; Ando H; Shimizu T; Okuhira K; Maruyama T; Otagiri M; Ishida T
    ACS Appl Bio Mater; 2021 May; 4(5):4302-4309. PubMed ID: 35006842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.